Make your money go further for just 25p per day

AIM IHT

Coronavirus impact: 29 April - surging profits and depression era declines

29/04/2020 · Alphabet (GOOGL)  · Anpario PLC (ANP)  · AstraZeneca (AZN)  · Diaceutics PLC (DXRX)  · EKF Diagnostics Holdings (EKF)  · Fevertree Drinks PLC (FEVR)  · Next (NXT)  · Novacyt SA (NCYT)  · NWF Group (NWF)  · Persimmon (PSN) 

AIM AIM Inheritance Tax potential Coronavirus Dividends UK US

Coronavirus impact: 29 April - surging profits and depression era declines

One of the world’s largest companies issued impressive results but the outlook is significantly more challenging. There was also some financial guidance at last from a small diagnostic group whose Covid-19 tests are in strong demand. Our latest update reveals more winners and losers from the current crisis


Alphabet: fabulous quarter but..

Google’s parent Alphabet Inc (US:GOOG), a constituent of our Ultimate Stocks portfolio, reported total revenue in the first quarter of $41.2bn, up 13% on the comparable period and ahead of consensus expectations of $40.8bn. Operating profit rose 21% to $8bn.

Advertising revenue through its Search category rose 8.6% to $24.5bn while advertising revenue through YouTube rose 33% to $4bn as it attracted a growing number of viewers in lock-down. Google Cloud, a…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

Have your say

Log in or register to view or add comments.

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Alphabet

Data wars underpin AI Wars

30/05/2023 · Portfolio

AI is the acronym of the moment, but data and data wars will determine the AI…


Ultimate Stocks updates: Tech giants impress

28/04/2023 · Portfolio

It’s quarterly reporting season and several of our US technology groups have led the way with…


More on Anpario PLC

Coronavirus impact: 9 Sept - a day of concrete results

09/09/2020 · Company Insights

Plenty of results and plenty of positives from AIM companies to encourage


Coronavirus impact: 25 June - cycling is having a great lockdown as this company demonstrates

25/06/2020 · Company Insights

Cycling and video gaming are at opposite ends of the leisure spectrum, but both have benefited…


More on AstraZeneca

AstraZeneca vs GlaxoSmithKline: a clear coronavirus winner?

31/07/2020 · Company Insights

The pharmaceutical industry has enjoyed a strong 2020. These are companies which – in the eyes…


Coronavirus impact: 29 April - surging profits and depression era declines

29/04/2020 · Company Insights

One of the world’s largest companies issued impressive results but the outlook is significantly more challenging.…


More on Diaceutics PLC

What is AIM’s exposure to Silicon Valley Bank?

14/03/2023 · Company Insights

One of AIM’s largest companies announced cracking full year results with a big increase in its…


Buybacks | Contract wins | Warnings | Insolvencies

14/12/2021 · Company Insights

Results and updates covered here, include results from one of AIM’s corporate undertakers, who patiently await…


More on EKF Diagnostics Holdings

Why bother with an update!

12/01/2021 · Company Insights

There are a broad range of trading updates covered here, but we can’t understand why one company bothered, when…


​Coronavirus impact: 9 Nov – a renewable energy day

09/11/2020 · Company Insights

Two pioneering companies supporting the renewable energy arena announced positive developments for their rapidly developing technologies.


More on Fevertree Drinks PLC

Compelling value | AI appeal

25/05/2023 · Company Insights

Results from an unusual investing company highlight its compelling value, while elsewhere there was news of…


Fevertree Drinks: is the valuation justified?

22/03/2023 · Company Insights

Shares in the premium mixer group rose strongly as it reported in-line results and, more significantly,…


More on Next

Are Next and Burberry ready for the new retail normal?

10/02/2021 · Company Insights

Like many traditional retailers Next and Burberry have both been severely disrupted by lockdown measures caused by…


Coronavirus impact: 29 July - a lesson in excellent financial reporting

29/07/2020 · Company Insights

The latest report from Next provides a lesson in comprehensive reporting, if only others would follow their lead


More on Novacyt SA

A refocused business delivers

30/09/2022 · Company Insights

Having survived a near death experience several years ago, a manufacturer of specialist industrial equipment covered…


Better than expected

17/06/2022 · Company Insights

Some welcome good news at last for shareholders in this provider of online competitions to win…


More on NWF Group

Upgrades and a big dividend payer

09/03/2023 · Company Insights

Results and updates from AIM covered here include excellent trading updates from two low profile businesses.…


Quality going cheap | Dividend joy

31/01/2023 · Company Insights

Results and updates covered here include one of the most forthright announcements we have seen from…


More on Persimmon

Do our Income Boosters need a housebuilder?

29/03/2021 · Portfolio

With UK housebuilders offering yields up to 8%, should we add one to our Income Boosters dividend…


Income Boosters: Does our dividend portfolio need a housebuilder?

18/09/2020 · Portfolio

Housebuilders have become income favourites in recent years, but our income portfolio doesn't have any exposure…


More Company Insights

A tale of two fund managers

Compelling value | AI appeal

Valuation difficulties

More on Alphabet

Data wars underpin AI Wars

Ultimate Stocks updates: Tech giants impress

AI wars are here - what should you be doing?

Ultimate Stocks: Recovery gathering momentum in 2023

More on Anpario PLC

Coronavirus impact: 9 Sept - a day of concrete results

Coronavirus impact: 25 June - cycling is having a great lockdown as this company demonstrates

Coronavirus impact: 29 April - surging profits and depression era declines

Anpario PLC (AIM: ANP) – Fantastic set of full year results

More on AstraZeneca

AstraZeneca vs GlaxoSmithKline: a clear coronavirus winner?

Coronavirus impact: 29 April - surging profits and depression era declines

Global investment round-up: this week’s top stories

The week at a glance: 22 July – results madness

More on Diaceutics PLC

What is AIM’s exposure to Silicon Valley Bank?

Buybacks | Contract wins | Warnings | Insolvencies

An exciting play on the growing market of diagnostic data analytics

Coronavirus impact: 7 Sept - seaweed secures the dosh

More on EKF Diagnostics Holdings

Why bother with an update!

​Coronavirus impact: 9 Nov – a renewable energy day

​Coronavirus impact: 2 Oct – a cheap technology play to close the week

Coronavirus impact: 14 Sept - game changing news

More on Fevertree Drinks PLC

Compelling value | AI appeal

Fevertree Drinks: is the valuation justified?

Plenty to encourage | Bonkers Bargain Upgrades

Big sell-off brings Director buying!

More on Next

Are Next and Burberry ready for the new retail normal?

Coronavirus impact: 29 July - a lesson in excellent financial reporting

High street retail: potential winners and losers in 2020

Coronavirus impact: 29 April - surging profits and depression era declines

More on Novacyt SA

A refocused business delivers

Better than expected

Upgrades in the AIM sell-off

A Covid tester is back in favour

More on NWF Group

Upgrades and a big dividend payer

Quality going cheap | Dividend joy

International ambitions to excite shareholders

5 small cap dividend stocks for yield and growth

More on Persimmon

Do our Income Boosters need a housebuilder?

Income Boosters: Does our dividend portfolio need a housebuilder?

Coronavirus impact: 29 April - surging profits and depression era declines

European expansion boosts IHT qualifying Michelmersh

More Company Insights

A tale of two fund managers
Compelling value | AI appeal
Valuation difficulties

Sign-up to our free email updates

SIGN UP